JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stengel, P. W.
Right arrow Articles by Cohen, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stengel, P. W.
Right arrow Articles by Cohen, M. L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

M1 Receptor-Mediated Nitric Oxide-Dependent Relaxation Unmasked in Stomach Fundus from M3 Receptor Knockout Mice

Peter W. Stengel, and Marlene L. Cohen1

Eli Lilly and Company, Lilly Research Laboratories, Neuroscience Research, Lilly Corporate Center, Indianapolis, Indiana

Muscarinic receptors can mediate both contractile and relaxant responses in smooth muscle. The stomach fundus from wild-type mice possesses a neuronal M1 receptor that mediates relaxation to carbamylcholine and (4-hydroxy-2-butynyl)-1-trimethylammonium-3-chlorocarbanilate chloride (McN-A-343) but is masked by M3 receptor-mediated contraction to both agonists. When the M3 receptor was deleted, cholinergic-induced relaxation was unmasked. M1 receptor antagonism with pirenzepine, nitric oxide (NO) synthase inhibition with N{theta}-nitro-L-arginine methyl ester hydrochloride, and inhibition of neuronal activation with tetrodotoxin abolished relaxation to McN-A-343 in tissues from M3 receptor knockout mice, supporting the neuronal localization of an M1 receptor that activated NO release to effect relaxation. However, the cyclooxygenase inhibitor indomethacin did not affect contraction or relaxation to carbamylcholine in stomach fundus from wild-type or M3 receptor knockout mice, indicating that cyclooxygenase products played no role in these responses. The neuronal M1 receptor modulated relaxation induced by carbamylcholine and McN-A-343 but not relaxation induced by electric field stimulation of the stomach fundus. These data support the presence of M1 receptor-mediated relaxation in the stomach and suggest that when the M3 receptor is eliminated or blocked, M1 receptor-mediated gastric relaxation may be enhanced, possibly leading to alterations in gastric emptying and subsequent effects on body weight.


Received July 26, 2002; accepted October 18, 2002.

Address correspondence to: Peter W. Stengel, Eli Lilly and Company, Lilly Research Laboratories, Neuroscience Research, Lilly Corporate Center, Indianapolis, IN 46285. E-mail: stengel_peter_w{at}lilly.com




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Toda and A. G. Herman
Gastrointestinal Function Regulation by Nitrergic Efferent Nerves
Pharmacol. Rev., September 1, 2005; 57(3): 315 - 338.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. C. Baccari, S. Nistri, S. Quattrone, M. Bigazzi, T. Bani Sacchi, F. Calamai, and D. Bani
Depression by Relaxin of Neurally Induced Contractile Responses in the Mouse Gastric Fundus
Biol Reprod, January 1, 2004; 70(1): 222 - 228.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.